🇺🇸 NT 201 in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Aortic Arteriosclerosis — 1 report (10%)
2. Cerebral Arteriosclerosis — 1 report (10%)
3. Cerebral Atrophy — 1 report (10%)
4. Condition Aggravated — 1 report (10%)
5. Disease Recurrence — 1 report (10%)
6. Encephalopathy — 1 report (10%)
7. Ischaemic Stroke — 1 report (10%)
8. Lacunar Infarction — 1 report (10%)
9. Mucous Membrane Disorder — 1 report (10%)
10. Muscular Weakness — 1 report (10%)

Source database →

Frequently asked questions

Is NT 201 approved in United States?

NT 201 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for NT 201 in United States?

Merz Aesthetics GmbH is the originator. The local marketing authorisation holder may differ — check the official source linked above.